Vimarsana
Biggest News Aggregation in the World

Page 3 - Impact Factor News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Impact Factor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Impact Factor Today - Breaking & Trending Today

The disregarded change of campus life - Vimarsana News

The disregarded change of campus life

Major happening of late 70s and of decade of 80s ripped students from their global identities

What is the environmental impact of cultivated meat? - Vimarsana News

What is the environmental impact of cultivated meat?

While the verdict is still out on the sustainability of cultivated meat production, a panel of experts during the Tufts University Cellular Agriculture Day on Jan. 11 in Boston, Mass., are optimistic, citing the need for expansive data sets on more diverse cell culture mediums, bioreactors and energy sources.

QU launches 20th issue of Qatar University Research Magazine - Vimarsana News

QU launches 20th issue of Qatar University Research Magazine

Doha: Qatar University (QU) announced the release of the twentieth issue of the Qatar University Research Magazine. The issue, according to QU, fea...

Dizal Impresses with Its Differentiated Hematological Oncology Portfolio at 2023 ASH - Vimarsana News

Dizal Impresses with Its Differentiated Hematological Oncology Portfolio at 2023 ASH

/PRNewswire/ -- Dizal presented compelling data from its robust portfolio of hematological oncology at the 65th American Society of Hematology (ASH) Annual...

Dizal's Golidocitinib Pivotal Trial Demonstrates Superior and Durable Clinical Benefits for Patients with r/r PTCL in Oral Presentation at 2023 ASH - Vimarsana News

Dizal's Golidocitinib Pivotal Trial Demonstrates Superior and Durable Clinical Benefits for Patients with r/r PTCL in Oral Presentation at 2023 ASH

Full analysis of multinational pivotal study results of golidocitinib in relapsed or refractory peripheral T-cell lymphoma (r/r PTCL) (JACKPOT8 PART B)...